Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.2.19 (
ubiquitin-protein ligase
)
799
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
KCNQ1
K(+) channel plays a key role in the regulation of several physiological functions, including cardiac excitability, cardiovascular tone, and body electrolyte homeostasis. The metabolic sensor AMP-activated protein kinase (AMPK) has been shown to regulate a growing number of ion transport proteins. To determine whether AMPK regulates
KCNQ1
, we studied the effects of AMPK activation on
KCNQ1
currents in Xenopus laevis oocytes and collecting duct epithelial cells. AMPK activation decreased
KCNQ1
currents and channel surface expression in X. laevis oocytes, but AMPK did not phosphorylate
KCNQ1
in vitro, suggesting an indirect regulatory mechanism. As it has been recently shown that the
ubiquitin-protein ligase
Nedd4-2 inhibits
KCNQ1
plasma membrane expression and that AMPK regulates epithelial Na(+) channels via Nedd4-2, we examined the role of Nedd4-2 in the AMPK-dependent regulation of
KCNQ1
. Channel inhibition by AMPK was blocked in oocytes coexpressing either a dominant-negative or constitutively active Nedd4-2 mutant, or a Nedd4-2 interaction-deficient
KCNQ1
mutant, suggesting that Nedd4-2 participates in the regulation of
KCNQ1
by AMPK.
KCNQ1
is expressed at the basolateral membrane in mouse polarized kidney cortical collecting duct (mpkCCD(c14)) cells and in rat kidney. Treatment with the AMPK activators AICAR (2 mM) or metformin (1 mM) reduced basolateral
KCNQ1
currents in apically permeabilized polarized mpkCCD(c14) cells. Moreover, AICAR treatment of rat kidney slices ex vivo induced AMPK activation and intracellular redistribution of
KCNQ1
from the basolateral membrane in collecting duct principal cells. AICAR treatment also induced increased ubiquitination of
KCNQ1
immunoprecipitated from kidney slice homogenates. These results indicate that AMPK inhibits
KCNQ1
activity by promoting Nedd4-2-dependent channel ubiquitination and retrieval from the plasma membrane.
...
PMID:AMP-activated protein kinase inhibits KCNQ1 channels through regulation of the ubiquitin ligase Nedd4-2 in renal epithelial cells. 2086 Oct 72